| abstract |
The present invention relates to a peptide capable of inducing cytotoxic T cells targeting cancer cells, wherein the peptide consists of an amino acid sequence derived from a polypeptide encoded by the Sox2 gene, or 1 in the amino acid sequence thereof. Alternatively, the peptide comprising an amino acid sequence in which several amino acids are deleted, substituted or added, and presented as an antigen by HLA-A24, the CTL induced by the peptide, the peptide and / or the CTL The present invention relates to a pharmaceutical composition. The invention further relates to the use of said peptides for CTL induction. |